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Summary statement: 
Rabbit fetuses with induced diaphragmatic hernia and treated with prenatal tracheal occlusion 
do have a similar pulmonary transcriptome as unaffected controls and provide a valuable 
database of gene expressions. 
 
Abstract: 
Congenital diaphragmatic hernia (CDH) is a malformation leading to pulmonary hypoplasia 
which can be treated in utero by fetal tracheal occlusion (TO). However the changes of gene 
expression induced by TO remain largely unknown but could be used to further improve the 
clinically used prenatal treatment of this devastating malformation. Therefore we aimed to 
investigate the pulmonary transcriptome changes due to surgical induction of diaphragmatic 
hernia (DH) and additional tracheal occlusion in the fetal rabbit model. 
Induction of DH was associated with 378 up-regulated genes compared to controls when 
allowing a false discovery rate (FDR) of 0.1 and a Fold Change (FC) of 2. Those genes were 
again down-regulated by consecutive TO. But DH+TO was associated with an up-regulation 
of 157 genes compared to DH and controls. When being compared to control lungs, 106 
genes were down-regulated in the DH group and were not changed by TO. Therefore, the 
overall pattern of gene expression in DH+TO is more similar to the control group then to the 
DH group. In this study we further provide a database of gene expression changes induced by 
surgical creation of DH and consecutive TO in the rabbit model. Future treatment strategies 
could be developed using this dataset. We also discuss the most relevant genes that are 
involved in CDH. 
  
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
Introduction 
The prevalence of congenital diaphragmatic hernia (CDH) ranges between 1-4/10,000 
births, which translates to 542 to 2,168 children in EU-27 every year (2008) (Kotecha et al. 
2012). It occurs as an isolated condition, associated with other anomalies or part of a genetic 
syndrome. Lung development is disturbed already from the embryonic period, but progresses 
because of herniation of the viscera through the defect into the chest, competing for space 
with the developing lungs. As a consequence, lungs of babies with CDH have fewer and less 
mature airway branches, a smaller cross-sectional area of pulmonary vessels, remodelled 
vascular architecture and an altered vasoreactivity (Kinsella et al. 2005). At birth, this leads to 
respiratory insufficiency and persistent pulmonary hypertension (PPHT). This is lethal in up 
to 30% of cases, despite prenatal referral to high volume centers that offer standardized 
neonatal care (Grushka et al., 2009; Hayakawa et al., 2013; van den Hout et al., 2011).  
In countries with prenatal ultrasound (US) screening practices, >60% of cases are 
diagnosed at the latest by the second trimester. In isolated cases an individualized prognosis 
can be made based on the degree of liver herniation and parenchymal lung size predicting 
mortality and early neonatal morbidity (Cannie et al., 2008; Claus et al., 2011; Cruz-Martinez 
et al., 2011; Jani et al., 2007; Jani et al., 2009; Mayer et al., 2011; Ruano et al., 2012). The 
ability to prenatally identify a future non-survivor enables clinicians to propose a prenatal 
intervention that avoids this outcome. Today the clinical method to stimulate lung 
development is fetal tracheal occlusion (TO). TO prevents egress of lung liquid, causing 
increased pulmonary stretch, which accelerates lung growth (DiFiore et al., 1994). This 
operation is currently evaluated within the framework of a randomized clinical trial, 
comparing Fetoscopic Endoluminal Tracheal Occlusion (FETO) to expectant management 
during pregnancy (Deprest et al., 2009) (Deprest et al., 2014).  
Because TO still fails to save half of the fetuses with severe CDH and carries a risk for 
preterm delivery, there is a need for alternative prenatal strategies. Preclinical evaluation of 
these therapies involves the use of animal models i.e. rodents, rabbits, and eventually lambs. 
Though in all mammalians, lung development progresses through five stages (embryonic, 
pseudoglandular, canalicular, saccular, alveolar), this is not at the same pace. (Pringle, 1986). 
This needs to be kept in mind when choosing an animal model in studies on lung 
development. For instance, rodents are “early” models as CDH is induced in the embryologic 
phase by the administration of a teratogen (Clugston et al., 2006; Keijzer et al., 2000). In 
those, nitrofen (NF) is prenatally administered at E11. 5 (mice) or E13.5 (rats), and effects are 
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studied at term, when lungs are in the canalicular to saccular phase (Beurskens et al., 2007; 
Correia-Pinto et al., 2010). All NF-exposed pups have lung hypoplasia, half of them also the 
diaphragmatic defect (Keijzer et al., 2000; Rottier and Tibboel, 2005; Schittny et al., 2000). 
These effects are believed to be caused by interference of NF with the retinoic acid (RA) 
signaling pathway, which is key in lung development (Malpel et al., 2000). This pathway is 
also disturbed in CDH in humans (Beurskens et al., 2009). 
In larger animals hypoplasia is induced by surgical creation of a diaphragmatic defect, 
typically in the pseudoglandular phase. Rabbits are widely available, have low housing needs, 
a timed gestation and large litter size. Rabbits alveolize in utero as in man (Roubliova et al., 
2010). Pups with diaphragmatic hernia (DH) display both histological and functional changes 
such as reduced airway and vascular development, and pathologic compliance, airway 
resistance, tissue damping and elastance – mimicking the clinical phenotype (Flemmer et al., 
2007; Roubliova et al., 2004; Wu et al., 2000). Gene expression of a number of critical 
signaling molecules relevant to alveolarization, angiogenesis and regulation of vascular tone, 
but not to surfactant production, have been shown to be disrupted just as in man (Vuckovic et 
al., 2013; Vuckovic et al., 2012). However a broader study on gene expression levels in this 
model has not been done so far. The use of RNA-Sequencing for transcriptome analysis has 
become increasingly widespread with the advent of massively parallel sequencing 
technologies, in part due to reductions in costs and increased throughput, and improved 
knowledge of non-model organism reference genomes. Therefore we wanted to investigate 
the pulmonary transcriptome after surgical induced DH creation and subsequent TO in the 
rabbit model. The provided gene expression database can be used to develop further treatment 
strategies for CDH. 
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Results 
At harvest there were seven surviving DH+TO fetuses (mean LBWR: 0,017; SD: 0,002; CI 
95%: 0,013 – 0,022) and seven DH fetuses (mean LBWR: 0,011; SD: 0,003; CI 95%: 0,003 – 
0,018). We also took one random control for every third litter (n=4) (mean LBWR: 0,016; 
SD: 0,001; CI 95%: 0,013 – 0,018). RNA integrity (RIN) values were determined which led 
to the exclusion of one DH+TO fetus. All six remaining fetuses from the DH+TO group were 
analyzed. We selected four (DH) fetuses displaying the best RIN values (data not shown). 
Principal component analysis (PCA) and unsupervised hierarchical clustering revealed 3 
DH+TO samples clustered together as a single homogenous group, and 2 DH+TO samples 
clustered with the DH group. Those 2 samples correlate with a clinical sub-group of non-
responders to the TO treatment which analysis was not the aim of our study. The remaining 
DH+TO sample was considered as a statistical outlier based upon QC correlation analysis and 
calculation of MAD scores using the Array Studio software, hence it was excluded from 
further analysis. This distinct gene expression pattern of DH+TO fetuses correlated with two 
patterns of lung growth, as evidenced by the lung-to-body-weight ratio, which is a pathologic 
measure of the degree of lung development (Table 1).  
 
Statistical inference analysis was performed between the groups defined above [DH (n=4), 
DH+TO (n=3), and control (n=4)] using the general linear model function in Array Studio 
(OmicSoft, Cary, US) to calculate fold change (FC) values and false discovery rate (FDR) 
values (applying the Benjamini–Hochberg procedure).  
PCA and unsupervised hierarchical clustering of those dysregulated genes in any group 
comparison (described above) demonstrated clustering of homogenous groups for DH, 
DH+TO and control as expected, and revealed that DH+TO and control groups were more 
comparable than the DH group (Supplementary Figure 1, 2).  
The heat map generated by the unsupervised hierarchical clustering for the total of 641 unique 
genes found to be dysregulated (FC +-2; FDR <0.1) in any group comparison is shown in 
Figure 1. This reveals three large gene clusters whose expression values define the changes 
due to DH and after treatment with TO. The first gene cluster containing of 157 genes (Figure 
1, top) demonstrates low expression in both DH and control, and high expression in DH+TO 
only. This cluster represents genes whose expression is induced by TO, but which are 
unchanged in DH. The second, and largest, gene cluster containing of 378 genes (Figure 1, 
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middle) demonstrates high expression in DH only and low expression in control and DH+TO. 
This cluster represents genes whose expression is induced by DH, and which are reversed to 
lower levels by subsequent TO. The third gene cluster containing of 106 genes (Figure 1, 
bottom) demonstrates high expression in controls, and low expression in both DH and 
DH+TO. This cluster represents genes whose expression is reduced following DH, and which 
remain expressed at low levels even after TO. 
To summarize, from the hierarchical cluster heat map shown in Figure 1 it is apparent that the 
major change in gene expression (Figure 1, gene cluster 2, middle) is up regulation of genes 
in DH, which are down regulated by TO, towards, or beyond, levels seen in the controls 
(normal state) at the same developmental time point. One subset of genes is unchanged by TO 
and remains expressed at low levels, and one subset is highly upregulated by TO in 
comparison to both control and DH without TO. 
The database of all dysregulated genes found in our study can be found in Supplementary 
Table 1. 
 
Pathway Analysis 
Analysis of the dysregulated gene sets for each comparison detailed above and for each of the 
gene clusters defined above was performed using the IPA web application (Ingenuity Pathway 
Analysis, Ingenuity Systems, Redwood City, CA, USA). Of the total 641 unique genes, 560 
genes were mapped within IPA to known functional genes with human, mouse or rat 
homologues. This gene set was used to create a protein-protein interaction (PPI) network 
where experimental evidence supports direct interactions (i.e. predictions and indirect 
interactions were not allowed) and orphan molecules were subsequently removed. The 
resulting network is displayed in Supplementary Figure 3, where the molecules are coloured 
according to the gene clusters identified in Figure 1 (blue = genes with significantly increased 
expression in DH compared to DH+TO and/or control; yellow = genes with significantly 
increased expression in DH+TO compared to DH and/or control; and green = genes with 
significantly decreased expression in DH and/or DH+TO in comparison to control).  
The Cytoscape plugin iRegulon (Janky et al., 2014) was used to identify potential 
transcription factors (TFs) of interest, using the 641 genes dysregulated in any comparison as 
the input. iRegulon searches for enrichment of cis-regulatory TF motifs in the target gene set, 
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and predicted FOXJ1 as a key regulatory TF in our study. The input list contains 139/641 
(22%) genes, which are ‘target’ genes of FOXJ1.  
In addition, we used the STEM application (Ernst and Bar-Joseph, 2006) to identify clusters 
of genes with similar changes in expression over time, or in our case the changes observed 
from control to disease (DH) to treatment (DH+TO). The input was the FC values for the 641 
genes significantly dysregulated in any comparison, where timepoint 1 is control data (i.e. 
FC=1), timepoint 2 is the CDH vs control data, and timepoint 3 is the TO vs control data. This 
identified 4 significant clusters containing genes with similar changes in expression profile, of 
which Profile 9 contained the largest number of genes and was of highest significance (Figure 
2, and Supplementary Table 2).  
Real Time Quantitative PCR (qPCR) 
PCR analysis of ten of the 12 analyzed genes yielded results that were in agreement with 
RNA sequencing data (Supplementary Figure 4). For eight genes, the differential expression 
between groups was concordant with the RNA-seq data  (p<0.05, u Mann Whitney test). 
However, qPCR did not show a significant increase of RFX3 and LRRQI1 in DH group 
compared to control (Supplementary Figure 5). For BMPR2 and PDE5A, qPCR failed to 
show any difference between DH and wild type This distinct gene expression pattern of 
DH+T fetuses correlated with two patterns of lung growth, as evidenced by the lung-to-body-
weight ratio, which is a pathologic measure of the degree lung development. although PDE5A 
was significantly down regulated in the TO group. 
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Discussion 
 In this study we describe for the first time the pulmonary transcriptome analysis of specimens 
obtained in a rabbit model for pulmonary hypoplasia. The latter was induced by creating a 
diaphragmatic defect during the pseudoglandular phase. Conversely  forced lung growth was 
induced by fetal TO at the transition of the canalicular to saccular phase. We found that the 
largest group of genes significantly dysregulated were 378 genes that were both upregulated by 
DH creation and downregulated by TO to a level similar to that of controls. Further this study 
gives a database of genes that are significantly influenced by DH creation and consecutive TO 
(Supplementary Table 1). This database can be used for further understanding of the disease 
process and development of treatment modalities for CDH. Below we discuss some of the most 
relevant genes that we found dysregulated. 
Relation of findings to previous gene expression analytical experiments in other models of CDH 
and/or TO 
Many studies have documented expression changes for numerous genes in association with 
CDH, and to a lesser extent also the effects of TO, all of this in various animal models of CDH. 
This is typically done by using PCR for selected genes, or using broader arrays, at least for 
experiments done in (nitrofen exposed) rodents, a species where molecular tools are abundantly 
available. Using a more modern technique such as RNA-Seq one can now also document and 
screen for changes in gene expression in relevant animal models for pulmonary hypoplasia and 
induced lung growth, even if the genome has not been completely been identified. We herein 
used this technology in rabbits, and studied dysregulations associated to pulmonary hypoplasia 
and tracheal occlusion. The latter is done to force lung growth which has been abundantly 
demonstrated in several animal models of CDH using other tools (Khan et al., 2007). In this 
experiment we confirmed the effects of TO on cell proliferation. MKI67 is a key cell 
proliferation marker and was significantly upregulated by TO. The effect of TO was in 
proportion to the pre-existing lung size (FC 3.6056, FDR 0.0874; TO vs control), a phenomenon 
already clinically demonstrated (Peralta et al., 2008). Other genes related to the mechanisms of 
TO in previous studies were identified. To name only one, AQP4 was upregulated in DH (FC 
2.3562, FDR 0.018) yet down to normal level after TO (FC -2.7286, FDR 0.0106). AQP4 is a 
transport molecule, which has previously been shown to be down regulated by stretch force on 
fetal lung AT2 cells in vitro (Wang et al., 2006).  
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TO is however in essence performed to enhance alveologenesis and reverse vascular changes 
that are typical to this disease. We observed dysregulation of Connective Tissue Growth Factor 
(CTGF). CTGF indeed enhances alveologenesis and microvascularisation during late lung 
development. CTGF was earlier shown to be upregulated by tracheal occlusion in the saccular 
phase of E21 rats (Burgos et al., 2010; Mesas-Burgos et al., 2009). In line with that, CTGF was 
in our rabbits also firmly upregulated by TO (FC 2.8135, FDR 0.0151). The same dysregulation 
was observed for a number of other genes earlier associated with DH and TO. BMPR2 
expression was up in DH (FC 1.9265, FDR 0.0228) and went down after TO (FC -2.7956, FDR 
0.0097). This gene encodes a member of the bone morphogenetic protein (BMP) receptor family 
of transmembrane serine/threonine kinases and the ligands of this receptor are the BMPs, which 
are members of the TGF-beta superfamily, and are involved in embryogenesis. Disruption of 
BMPR2 activity and downstream signaling has been demonstrated in the nitrofen rodent model 
of CDH (Gosemann et al., 2013; Makanga et al., 2013). BMPR2 plays a key role in pulmonary 
vasculogenesis during the late stages of fetal lung development and is essential for control of 
endothelial and smooth muscle cell proliferation. Dysfunction of BMPR2 and downstream 
signaling have been shown to disturb the crucial balance of proliferation of smooth muscle cells 
contributing to the pathogenesis of human and experimental pulmonary hypoplasia. In line with 
that was downregulation of BMP7 in DH, yet significant upregulation by TO (FC 2.311, FDR 
0.0163). BMP7 was reportedly down regulated in the lungs of the nitrofen rodent (Makanga et 
al., 2013).  
We were however mainly interested in the RNA-Seq technology because it has the potential to 
identify new targets that are involved in the condition and that can respond to prenatal 
intervention. One example is that DH in our rabbits was associated with a significant increase in 
PDE5A gene expression. The latter has been well documented in rodents and sheep, and it has 
been tied to the postnatal problem of pulmonary hypertension. The interesting observation here 
is that TO dramatically reduced PDE5A gene expression (FC= -2,49; FDR = 0,0097). PDE5A 
gene expression may also be altered by an alternative prenatal intervention, i.e. the transplacental 
administration of drugs. Sildenafil, which is already used to treat persistent pulmonary 
hypertension of the newborn (Noori et al., 2007), was recently shown to effectively inhibit 
cGMP-specific phosphodiesterase Type 5 in utero. In the latter experiment nitrofen rodents were 
used, and we confirmed a similar effect in rabbits and others in the fetal lamb (Luong et al., 
2011; Russo et al., 2015; Shue et al., 2014).  
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Future application: single cell type populations 
When starting from our RNA-seq data, the Cytoscape plugin iRegulon predicted that over 20% 
of dysregulated genes were target genes of FOXJ1. FOXJ1 is a marker for ciliated cells; it is 
actually involved as a transcription factor in ciliogenesis. To our knowledge it has so far not been 
named in DH. Our experiments demonstrate that DH rabbit pups display upregulation of FOXJ1, 
whereas it was down regulated after TO. Other ciliated cell marker genes (CCDC19, SPAG17, 
CCDC39, LRRIQ1, EFHC1, LRRC23, TTC18, WDR16, FANK1, ENKUR, CCDC113) were 
also upregulated in DH lungs compared to controls, and downregulated by TO to levels lower 
than in controls. These findings may point to an increased numbers of ciliated cells in DH lungs, 
which is reversed by TO. Loss of ciliated cells after TO has been earlier described in the upper 
conducting airways in fetal lambs with CDH though that study did not quantify changes in the 
more distant airways (Deprest et al., 2000). The study of effects of DH and TO on the variety of 
individual lung cell types can benefit from modern technology such as single cell RNA-seq 
(Treutlein et al., 2014). Those investigators applied this to the developing distal lung epithelium 
in the mouse which revealed a number of putative markers next of ciliated cells, Clara cells, AT1 
cells and AT2 cells. A number of genes in our data are also present within the top 30 putative 
markers for each lung cell type (both known and novel) previously identified in the Treutlein et 
al. study (Table 2). For instance, also Clara cell markers SCGB1A1, PPAP2B, and KDR 
(VEGFR2) were upregulated in DH, and subsequently down regulated, after TO. These findings 
are consistent with findings in rodents (Asabe et al., 1998) (Santos et al., 2007).  
Discordant findings and limitations.  
The above is a simplified interpretation and biased presentation of our results. First we identified 
a number of discrepancies in results between rabbits and other models. For example, AQP4, 
TGFBR3, EPAS1 and TGFB-I were upregulated in rabbits with CDH, whereas they were down 
regulated in the nitrofen rat. In rodents, DH is induced early in gestation by a teratogen 
interfering directly with the RA pathway, whereas in rabbits a surgical defect is created beyond 
mid gestation. This means that in both models different mechanisms or pathways are involved. 
Therefore, prenatal interventions may have different effects. For instance maternal retinoic acid 
administration in rabbits does not affect the gross anatomical, morphological or proliferative 
characteristics (Gallot et al., 2008), whereas it rescues lungs in nitrofen rats (Montedonico et al., 
2006). Next to that there are also significant differences between the time points in gestation 
and/or lung development at what time prenatal interventions are done.  
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Actually, the largest effect measured was that for WNT inhibitor factor 1 (WIF-1) gene 
expression (up in DH (FC 8.8107, FDR 0.0153) and down after TO (FC -4.1432, FDR 0.0272)). 
However, WIF-1 down regulation was earlier reported in the nitrofen rodent lungs during the 
saccular stage of lung development (Fujiwara et al., 2012). WNT signaling plays an essential 
role in embryonic development. WIF1 is a target gene of SMAD1 in the developing lung 
epithelial cells and acts to inhibit WNT proteins. SMAD1 plays a key role in organogenesis 
including lung development and maturation, and SMAD1 knockout mice display reduced 
sacculation, which is an important feature of pulmonary hypoplasia. How this needs to be tied 
together with our rabbit data remains unclear.  
In addition to that we observed changes that were different from what was previously described 
in clinical specimens. One example is that of the endothelin receptors EDNRA and EDNRB, 
which play a complex role in vascular tone. They are over-expressed in the thickened media of 
the pulmonary arteries of newborns with CDH (de Lagausie et al., 2005), as well as in the 
nitrofen rodent model (Dingemann et al., 2010). Binding of endothelin 1 to its receptor EDNRA 
on pulmonary artery smooth muscle cells results in vasoconstriction, whereas binding to the 
receptor EDNRB present on endothelial cells, results in vasodilation mediated by endogenous 
nitric oxide. In our rabbit model however EDNRB was not differently expressed in DH.  
We also observed discrepancies between the effects of DH and TO within the rabbit model. For 
instance c-fos induced growth factor (FIGF, also known as vascular endothelial growth factor D, 
VEGFD) was down regulated in CDH as well as following TO. This is a member of the 
PDGF/VEGF family activating VEGFR2 and VEGFR3 receptors. As it was not differentially 
expressed in the controls we assume it was not involved. Conversely, VEGFR2 was upregulated 
in DH (FC 1.7819, FDR 0.0281) and down to normal levels after TO (FC -2.321, FDR 0.0121), 
which demonstrates the complex interactions of these factors.  
We further had a number of discrepancies between RNA-Seq and qPCR, to which we pointed 
already when reporting on results for RFX3, LRRQL1, BMPR2 and PDE5A. Such discrepancies 
have been observed in previous reports (Duressa et al., 2013; Shi and He, 2014). This lack of 
concordance may be due to the poor knowledge of the rabbit genome and the absence of any 
SNP database which could result in a poor primer design for certain genes. 
Additionally we acknowledge several other limitations to our study. The sample size is small yet 
it matches financial limitations and is in line with the sample size of other studies analyzing the 
gene expression changes by TO in DH. Another is that the study of gene expression in whole 
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lung samples will not detect changes occurring in individual cell types or different areas along 
the airways. These add to the generic limitations of translational studies in animal disease 
models, of which the clinical relevance remains uncertain. Another limitation of the study is that 
the surgical model does not fully recapitulate the etiology of the disease.  
In conclusion we first describe the pattern of dysregulated pulmonary gene expression in lungs 
of fetal rabbits with surgically induced DH. Interestingly, tracheal occlusion, which is currently 
investigated as a prenatal surgical method to reverse pulmonary hypoplasia, is associated with a 
gene expression pattern that is comparable to what was observed in littermates with normal lung 
development. 
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Material and Methods 
Surgery 
The animal experiments were approved by the Ethics Committee of the Faculty of Medicine of 
the KU Leuven and all animals were treated according to current guidelines on animal wellbeing. 
In total 12 does of New Zealand white rabbits (Oryctolagus cuniculus) were operated and 
premedicated after weight estimation with ketamine 50 mg/kg (Ketamine 1000 CEVA®; CEVA 
Santé Animale, Brussels, Belgium), xylazine 6 mg/kg (Vexylan®; CEVA Santé Animale), and 
buprenorphine 0.03 mg/kg (Vetergesic®; Reckitt Benckiser Healthcare, Brussels, Belgium), all 
injected intramuscularly. General anesthesia was maintained using isoflurane 1.5% (Isoba® Vet; 
Abbott Laboratories Ltd., Queensborough, Kent, UK) in oxygen at 1 L/minute via a facemask. 
Maternal heart rate and oxygen saturation were monitored with a pulse oxymeter (Nellcor® N-
20P; Nellcor Inc., Haasrode, Belgium). Physiologic body temperature was maintained by a 
heating pad. The doe was placed in the supine position, the abdominal wall was shaved and 
disinfected with povidone iodine (Isobetadine®; Asta Medica, Brussels, Belgium) and covered 
with sterile drapes. Aseptic conditions were maintained throughout all surgical procedures. We 
operated on two fetuses in each doe, located in the middle of the left or right uterine horn. First 
diaphragmatic hernia (DH) was created at 23 days gestational age (GA). A second operation was 
performed at 28 days GA on the previously operated fetuses, either tracheal occlusion (DH+TO 
group), or sham neck dissection and skin closure (DH group). The latter is performed to include 
the effects of the fetal surgery per se. Before and after surgery, animals were housed in separate 
cages at normal room temperature and daylight, with free access to food and water. At 30 days 
GA, the does were euthanized with an intravenous bolus of a mixture of embutramide 200 mg, 
mebezonium 50 mg, and tetracaine hydrochloride 5 mg (0,3 mL/kg T61; Marion Roussel 
Hoechst, Brussels, Belgium) after previous premedication as described above. All operated 
fetuses as well as one control unoperated littermate (control group) were euthanized in utero and 
harvested by cesarean section to obtain non-ventilated lungs.  
 
Harvesting and sample preparation 
During necropsy, the fetus and its lungs were weighed on a scale measuring accurately up to 
0.001 g (HF 2000; A&D Instruments, Haasrode, Belgium) and the lung-to-body weight ratio 
(LBWR) was calculated.  
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Lung development is reflected by the lung-to-body weight ratio and pathologists have defined 
critical cut offs for pulmonary hypoplasia. We minimized contamination of the pulmonary tissue 
with other sources of DNA/RNA by flushing the lungs with saline by vascular access through the 
right ventricle of the fetal heart. The parenchymal lung tissue i.e. without the trachea was stored 
in RNAlater (Qiagen Benelux B.V., Venlo NL) at -4°C immediately.  
 
RNA isolation 
RNA isolation was performed on the entire left lung within 4 hours of harvesting using the 
RNeasy mini kit (Qiagen Benelux B.V., Venlo NL). Tissue lysis and homogenization was 
performed in 1200 µL Buffer RLT using the TissueLyser system (Qiagen Benelux B.V., Venlo, 
The Netherlands). Following tissue disruption and homogenization, samples were centrifuged for 
3 minutes at 14,000 rpm in a benchtop microcentrifuge. Lysate was transferred to fresh tubes and 
an equal volume of 70 % ethanol was added. 600 µL of sample was added twice to a spin 
column, with 2 RNeasy spin columns used per sample. Following wash steps RNA was eluted in 
50 µL RNAse-free H2O. 
Total RNA quantification was performed using the Nanodrop 1000 spectrophotometer (Thermo 
Scientific, Aalst, Belgium). RNA integrity was assessed using the RNA 6000 Nano Kit and the 
Bioanalyser (Agilent Technologies, Diegem, Belgium) according to the manufacturer’s 
recommendations. 
 
RNA sequencing Library Preparation 
One µg of total RNA was used as input material for sequencing library preparation, which was 
performed with the TruSeq RNA Library Preparation Kit (Illumina, Eindhoven, NL) according 
to the manufacturers protocol. Fragmentation was performed for 6 minutes. 8 PCR cycles were 
used for the PCR enrichment step. Samples were indexed to allow for multiplexing.  Sequencing 
libraries were quantified using the Qubit fluorometer (Life Technologies Europe BV, Gent, 
Belgium). Library quality and size range was assessed using the Bioanalyser (Agilent 
Technologies) with the DNA 1000 Kit (Agilent Technologies) according to the manufacturers 
recommendations. 
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RNA sequencing 
Individual libraries were diluted to a final concentration of 2nM and pooled for sequencing. 
Pooled libraries were sequenced in a single lane of an Illumina HiSeq2000 flow cell generating 
single end 50bp reads. At least 10 million reads were obtained for all samples (range 12-32 
million reads). 
 
Data Analysis 
Fastq files were mapped to the rabbit genome and transcriptome (OryCun2.0 retrieved from 
Ensembl, release 69) with the Array Studio software (OmicSoft, Cary, NC, USA) using default 
parameters for single short read data. Between 72% and 78% of reads mapped uniquely to the 
reference genome and/or transcriptome, and a further 6% to 8% of reads mapped non-uniquely. 
Between 16% and 18% of reads were unmapped. Expression values were calculated per gene; 
normalized to ‘reads per kilobase per million reads’ (RPKM) values as previously described 
(Mortazavi et al., 2008). Data was filtered to remove those genes with expression of <1RPKM in 
all samples. The RPKM expression values for the remaining 11,267 genes were subsequently 
Log2 transformed for downstream principal component analysis (PCA), hierarchical clustering, 
and for the subsequent calculation of fold changes by statistical inference analysis. All data are 
made available via ArrayExpress (accession number: E-MTAB-3452). 
 
Hierarchical clustering 
Hierarchical clustering was performed using the Array Studio software application, selecting 
‘Complete’ for link option, and ‘Correlation’ for distance option. The ‘Correlation’ setting is also 
named "Centered Pearson" 1 - corr(x , y), and the source algorithms are further described in 
http://cran.r-project.org/web/packages/amap/amap.pdf. Clustering is based upon the Log 
transformed RPKM gene expression values. 
 
Downstream Analysis 
Downstream pathway analysis and creation of networks was performed using the Ingenuity 
Pathway Analysis (IPA) software application (Ingenuity Systems, Redwood City, CA, USA). 
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The iregulon plugin was used with the Cytoscape analysis software (http://www.cytoscape.org/) 
for prediction of upstream transcription factors of interest (Janky et al., 2014). The short time-
series expression miner (STEM) application (Ernst and Bar-Joseph, 2006) was used to identify 
gene clusters with similar changes in expression between control and CDH, and following TO. 
 
 Real Time Quantitative PCR (qPCR) 
In order to confirm RNA sequencing findings, we selected for qPCR (quantitative polymerase 
chain reaction) 12 genes with FC> 2 or FC< (-2) and the house-keeping genes SDHA, TOP1 and 
GAPDH that were previously shown to be among the most stable genes in CDH rabbit model 
and after TO (Vuckovic et al., 2013). PCR primers were designed using Primer 3 software and 
Primer-BLAST. The absence of secondary structure was checked by the Vector NTI program. 
All the primers were synthesized by Integrated DNA Technologies.  
For a given gene, all samples were analyzed in the same qPCR run. Ten µL reactions were 
prepared using 2× LightCycler 480 SYBR Green I Master (Roche Applied Science) with 2 µL of 
a 1∶10 cDNA dilution and a final concentration of 300 nM of each primer. Data were analysed 
using the LightCycler 480 Software (Roche Applied Science). The results were quantified using 
the comparative threshold cycle method as described by Livak and Schmittgen (Livak and 
Schmittgen, 2001). In addition, serial dilutions were used to create standard curves for relative 
quantification and the expression of each gene was normalized to at least two of the three house-
keeping genes’ expression. The sequences and the different primers and the corresponding PCR 
efficiencies are provided in supplementary table 3. 
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Figures 
 
 
 
 
Figure 1: Heatmap generated by unsupervised hierarchical clustering of individual sample level 
data (Log2 transformed RPKM expression values per gene) for the 641 unique genes found to be 
dysregulated in any group comparison, demonstrating that the different groups (DH, WT, and 
TO) cluster together.  Samples are clustered on the horizontal axis and genes on the vertical axis.  
Gene expression values are shown as red for high expression and green for low expression, 
intensity reflects the level.  This reveals three large gene clusters, labelled as 1, 2, 3.  Information 
on Gene names, Fold Changes and FDR values for the groups comparisons, and Gene Cluster 
and STEM profile number are provided in Supplementary Table 1. 
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Figure 2: Shows the 4 significant gene profiles identified using the STEM application. Three 
timepoints are visible on the plots, representing changes in expression of the respective gene 
clusters from controls to DH, and DH treated with TO, respectively. Profile number is displayed 
in the top left, p-value bottom left. 
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Tables 
 
Table 1: In this table the three different groups (control, DH, DH+TO) are shown, containing 
fetal bodyweight, total fetal lung weight, weight of the left lung (LL), weight of the right lung 
(RL) and LBWR after harvesting at 30 days' GA. Excluded samples are specified. 
DH/DH+TO/Contr excluded 
Total lung 
weight LLweight RLweight Bodyweight LBWR 
DH yes 0,438 0,142 0,296 50,03 0,009 
DH yes 0,558 0,172 0,386 46,62 0,012 
DH yes 0,546 0,212 0,334 33,35 0,016 
DH 
 
0,506 0,121 0,385 36,14 0,014 
DH  0,334 0,104 0,230 41,75 0,008 
DH 
 
0,399 0,128 0,271 36,27 0,011 
DH 
 
0,390 0,141 0,249 43,33 0,009 
DH+TO yes 0,376 0,093 0,226 29,16 0,013 
DH+TO yes 0,434 0,127 0,272 30,36 0,014 
DH+TO yes 0,310 0,105 0,205 29,94 0,010 
DH+TO yes 0,421 0,115 0,306 31,23 0,013 
DH+TO   0,583 0,207 0,376 34,29 0,017 
DH+TO   0,627 0,118 0,509 39,19 0,016 
DH+TO   0,738 0,081 0,657 36,90 0,020 
Control 
 
0,546 0,235 0,311 36,41 0,015 
Control  0,583 0,229 0,354 34,29 0,017 
Control   0,512 0,257 0,276 34,13 0,015 
Control   0,459 0,223 0,236 32,79 0,014 
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Table 2: Table of marker genes for different lung cell types which are revealed to be 
significantly dysregulated in one or more comparisons (DH vs control; DH+TO vs DH; DH+TO 
vs control). Marker genes are defined from the top 30 known and novel putative marker genes 
reported by Truitlein et al. 
Markers of Lung Cell Types DH vs Control DH+TO vs DH DH+TO vs 
Control 
STEM 
Profile 
 FC FDR FC FDR FC FDR  
AT2 Cell Markers        
CD36 -1.574 0.0645 -1.6024 0.0651 -
2.5222 
0.0445 --- 
CHI3L1 -2.6009 0.0656 1.3452 0.5505 -
1.9335 
0.3014 4 
DLK1 3.1566 0.0754 1.6257 0.4332 5.1317 0.0969 15 
AT1 Cell Markers        
CLIC5 1.4758 0.0638 -2.6291 0.0097 -
1.7815 
0.0827 9 
AHNAK 1.5615 0.386 -4.6513 0.0266 -
2.9787 
0.1637 9 
LIMCH1 1.3993 0.2078 -2.2892 0.0229 -1.636 0.2011 9 
Clara Cell Markers        
SCGB1A1 1.2778 0.3533 -8.2686 0.0078 -
6.4711 
0.0151 --- 
PPAP2B 1.6128 0.0436 -2.1248 0.0142 -
1.3174 
0.3054 9 
KDR (VEGFR2) 1.7819 0.0281 -2.321 0.0121 - 0.3262 9 
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1.3025 
Ciliated Cell Markers        
FOXJ1 1.5702 0.2284 -2.0111 0.0968 -
1.2808 
0.6416 9 
CCDC19 1.4553 0.2369 -2.3 0.0366 -
1.5805 
0.2945 9 
SPAG17 2.0341 0.024 -2.3987 0.0138 -
1.1792 
0.6012 9 
CCDC39 2.0141 0.031 -3.1263 0.0107 -
1.5522 
0.2233 9 
LRRIQ1 2.1908 0.0306 -3.2301 0.0123 -
1.4744 
0.311 9 
EFHC1 1.5074 0.1071 -2.29 0.0181 -
1.5191 
0.2262 9 
LRRC23 1.4244 0.3106 -2.4415 0.0412 -
1.7141 
0.2747 9 
TTC18 1.7167 0.0702 -2.3818 0.0213 -
1.3874 
0.371 9 
WDR16 1.3893 0.1488 -2.4702 0.0128 -
1.7781 
0.1077 9 
FANK1 1.3534 0.3871 -2.2848 0.0523 -
1.6882 
0.2853 9 
ENKUR 1.4917 0.2823 -2.5538 0.0422 -
1.7119 
0.2973 9 
CCDC113 1.4899 0.1396 -2.4036 0.019 -
1.6133 
0.2064 9 
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Translational Impact:  
Clinical issue: Congenital diaphragmatic hernia (CDH) is a congenital malformation that can be 
nowadays treated prenatally by fetoscopic endolumnial tracheal occlusion (FETO). This 
treatment is currently under investigation in a multicenter randomized controlled trial. However 
the changes in gene expression induced by this treatment remain unknown. The rabbit model for 
CDH is well described and was used in this study for pulmonary transcriptome analysis after 
surgical creation of diaphragmatic hernia (DH) and consecutive fetal tracheal occlusion. 
Results: In this study we saw that the gene expression profile of fetuses treated with tracheal 
occlusion after DH induction was more comparable to unaffected controls then to those with DH 
only. We also performed a pathway analysis and provide with this study a database that could be 
used to further improve the prenatal treatment of CDH. 
Implications and future directions: Future prenatal treatments for CDH will have to be 
compared with FETO for their changes in pulmonary gene expression. There is an urgent need to 
decrease the invasiveness of fetoscopic procedures and to improve the efficiency of FETO. The 
herein provided database could be used to develop adjuvant therapies or transplacental therapies 
to fulfill that need.  
